PRESS RELEASES

24 November |  2021

Prilenia to Present at the 4th Annual Evercore ISI HealthCONx Conference 

Naarden, NL, 24 Nov 2021  Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announced that Dr Michael R. Hayden, MD, PhD Chief Executive Officer, will participate in a virtual fireside chat at the 4th annual Evercore ISI HealthCONx Conference on Thursday, Dec 2, 2021 at 1:25 p.m. ET. 
 

Details on changes to presentation dates/times can be found on the Company's website. Please check www.prilenia.com for the latest information.